Heinz-Josef Lenz
机构: University of Southern Califfornia
每年引用次数
引用次数
引用: 85,007
H-指数: 123
I10-指数 : 635
出版物: 1,649
Histone deacetylase inhibitors downregulate thymidylate sythnase expression and interact synergistically with fluoropyrimidines in colon cancer cell lines
Eva Borucka , Robert Ladner , Heinz-Josef Lenz , William Fazzone
Cancer Research 67 692 -692
2007
ERCC1 gene polymorphism as a predictor for clinical outcome in advanced colorectal cancer patients treated with platinum-based chemotherapy.
Denice Tsao-Wei , Jan Stoehlmacher , Susan Groshen , Wu Zhang
Clinical advances in hematology & oncology 1 ( 3) 162
123
2003
Antiangiogenic agents in cancer therapy.
Heinz-Josef Lenz
Oncology 19 ( 4) 17 -25
29
2005
Colon cancer stem cells: a new target in the war against cancer.
Heinz-Josef Lenz
Gastrointestinal cancer research : GCR 2 ( 4) 203 -204
4
2008
Individualization of therapy for colorectal cancer based on clinical and molecular parameters.
Alexandra Pohl , Heinz-Josef Lenz
Gastrointestinal cancer research : GCR 2
6
2008
Predictive and prognostic markers in colorectal cancer.
Robert D Ladner , Peter M Wilson , Heinz-Josef Lenz
Gastrointestinal cancer research : GCR 1 ( 6) 237 -246
15
2007
Accomplishments in 2007 in biologic markers for gastrointestinal cancers.
Patrick Johnston , Heinz-Josef Lenz
Gastrointestinal cancer research : GCR 2
2008
Molecular Mechanisms of Resistance to Anti-VEGF Therapies: Il-8 and its Receptors
Heinz-Josef Lenz
Clinical Cancer Research 13
2007
The c-MET-JAK1/2-STAT3 signalling axis is a critical mediator of drug resistance in Kras mutant colorectal cancer
Sandra Van Schaeybroeck , Murugan Kalimutho , Philip Dunne , Robbie Carson
National Cancer Research Institute
2012
Microsatellite instability in colorectal cancer: overview of its clinical significance and novel perspectives.
Heinz-Josef Lenz , Francesca Battaglin , Madiha Naseem , Mohamed E Salem
Clinical advances in hematology & oncology 16 ( 11) 735 -745
33
2018
Identification of a Genomic Region Between SLC29A1 and HSP90AB1 Associated With Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance)
Bert H. O’Neil , James N. Atkins , Bryan P. Schneider , Kouros Owzar
PMC
15
2019
How we treat left-sided vs right-sided colon cancer.
Diana L Hanna , Heinz-Josef Lenz
Clinical advances in hematology & oncology 18 ( 5) 253 -257
1
2020
Molecular characterization of pancreatic cancers as seen in the SLUG gene revealing cancer progression.
Emil Lou , Anthony Frank Shields , Joanne Xiu , Andreas Seeber
Journal of Clinical Oncology 39 433 -433
1
2021
PULSE: A randomized phase II open label study of panitumumab rechallenge versus standard therapy after progression on anti-EGFR therapy in patients with RAS wild-type metastatic colorectal cancer (mCRC).
Ryan Bruce Corcoran , Andrea Cercek , Scott Kopetz , John H. Strickler
Journal of Clinical Oncology 39
2021
Genetic variants involved in the lipid metabolism pathway to predict outcome in patients (pts) with metastatic colorectal cancer (mCRC): Data from FIRE-3 and MAVERICC trials.
Chiara Cremolini , Fotios Loupakis , Alfredo Falcone , Wu Zhang
Journal of Clinical Oncology 39 118 -118
2021
GDF15 expression in metastatic colorectal cancer.
Emil Lou , Joanne Xiu , Priya Jayachandran , Wu Zhang
Journal of Clinical Oncology 39 116 -116
1
2021
Single nucleotide polymorphisms (SNPs) in endoplasmic reticulum (ER) stress response genes to predict first-line treatment outcome in patients (pts) with metastatic colorectal cancer (mCRC): Data from the MAVERICC and FIRE-3 trials.
Volker Heinemann , Heinz-Josef Lenz , Francesca Battaglin , Sebastian Stintzing
Journal of Clinical Oncology 39 103 -103
2021
Polymorphisms of pluripotency transcription factors for predicting cetuximab efficacy in metastatic colorectal cancer: Data from FIRE-3 and TRIBE trials.
Jingyuan Wang , Natsuko Kawanishi , Zhang Wu , Chiara Cremolini
Journal of Clinical Oncology 39 98 -98
1
2021
MOUNTAINEER-02: Phase II/III study of tucatinib, trastuzumab, ramucirumab, and paclitaxel in previously treated HER2+ gastric or gastroesophageal junction adenocarcinoma—Trial in Progress.
Eric Van Cutsem , Daniel V.T. Catenacci , Maria Corinna Palanca-Wessels , Takayuki Yoshino
Journal of Clinical Oncology 39
1
2021
Health-related quality of life and time from diagnosis among young adult colorectal cancer survivors.
David R. Freyer , Afsaneh Barzi , Joel Milam , Kimberly Ann Miller
Journal of Clinical Oncology 39 34 -34
2021
WU ZHANG Alfredo Falcone Francesca Battaglin Axel Grothey Shivani Soni Fotios Loupakis Martin D. Berger Howard S. Hochster Alberto Puccini Federico Innocenti Georg Lurje Salvatore Siena Scott Kopetz Yu Sunakawa Thierry André Bert O'Neil Armin Gerger chiara cremolini Anthony El-Khoueiry Fortunato Ciardiello